Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait Ability in Patients With Hip Joint Diseases

NCT07147530 · Yonsei University · Updated 29 Aug 2025

What is being tested
Electrically Powered Orthopedic Exercise Device
For
Hip Disease
Kind of study
Tests a treatment or device on volunteers. Phase 4.
Who can join
Ages 19 years and older. About 30 people. The full rules are on the registry page.
Where
South Korea
When
Starts or started 7 April 2025, ends 6 April 2026. Registered 29 Aug 2025.
Results
None posted yet.

In the researchers' words

Gait is an essential daily activity performed through the complex coordination of the central and peripheral nervous systems and the musculoskeletal system. Gait disorders can negatively affect quality of life, increase the risk of falls, decrease the ability to perform daily activities, and limit physical activity. Various musculoskeletal diseases can cause gait impairment, with hip osteoarthritis and osteonecrosis of the femoral head (ONFH) being the most representative conditions. Various interventions can be attempted during the early stages of hip joint disease progression. However, improvement in symptoms does not necessarily indicate a halt in disease progression. As the condition advances in most patients, thinning of the full-thickness hip cartilage or collapse of the femoral head occurs, leading to restricted hip range of motion, weakness of the lower limb muscles and functional deterioration, resulting in the need for total hip arthroplasty. THA offers significant improvements in pain relief and function, regardless of the patient's preoperative status, and can reduce long-term healthcare costs. However, performing THA at an early stage with minimal functional improvement is not recommended. Postoperative complications, such as infections, aseptic loosening, and instability, are potential risks, with younger patients aged 45-64 showing higher revision surgery…
ClinicalTrials.gov, NCT07147530

Sites

  • Yongin Severance HospitalYongin-si, Gyeonggi-do, South Korea, South Korea